Supply: metamorworks / Shutterstock
Oscar Well being (NYSE:OSCR) inventory is heading increased on Tuesday after the healthcare firm introduced Mark Bertolini as its new CEO.
That information has holders of OSCR inventory excited at the moment as Bertolini is a veteran within the healthcare area. Previous to becoming a member of Oscar Well being, he served because the CEO of medical health insurance firm Aetna earlier than it was purchased by CVS Well being (NYSE:CVS).
This may see Bertolini take over as the following CEO of Oscar Well being beginning in April. That may see him change present CEO and founder Mario Schlosser. This comes as Oscar Well being seeks to develop into a worthwhile medical health insurance firm, stories Reuters.
OSCR Inventory Reactions On Tuesday
Buyers are excited concerning the thought of Bertolini taking up as the brand new CEO of Oscar Well being. That is smart contemplating his prior success with Atena. He offered that firm to CVS Well being in 2018 for a whopping $70 billion. If he can carry the identical worth to this firm, OSCR inventory ought to profit.
Already merchants are piling into OSCR inventory at the moment, which brings with it heavy buying and selling. That has some 35 million shares of the inventory altering fingers as of this writing. To place that in perspective, the corporate’s day by day common buying and selling quantity is nearer to 1.6 million shares.
OSCR inventory is up 82% as of Tuesday morning.
There’s extra inventory market information value speaking about under!
We’ve rounded up the entire most up-to-date inventory market protection merchants must find out about on Tuesday! Amongst that’s what has shares of Paramount (NASDAQ:PARA), Chook International (NYSE:BRDS), and Lyft (NASDAQ:LYFT) inventory transferring at the moment. You’ll find extra on these issues on the following hyperlinks!
Extra Tuesday Inventory Market Information
On the date of publication, William White didn’t have (both instantly or not directly) any positions within the securities talked about on this article. The opinions expressed on this article are these of the author, topic to the InvestorPlace.com Publishing Pointers.
